Data is not available for this company.
Data is not available for this company
Surya Pharmaceutical incorporated in 1992, is engaged in manufacturing of active pharmaceutical ingredients (API's), finished drug formulations (FDF's), fine intermediates, herbal products, and mint/menthol derivatives. The company has client based in over 90 countries across the globe.
The company has received ISO 9001-2000 certifications for its quality management. The company is listed on the Bombay Stock Exchange and the National Stock Exchange. The company has employee strength of
The company has received ISO 9001-2000 certifications for its quality management. The company is listed on the Bombay Stock Exchange and the National Stock Exchange. The company has employee strength of more than 2000 people. Company offices located at Shanghai, Singapore, Europe and the United States of America (USA).
Company has production capacity of 600 million of capsules and tablets each per annum.
Intermediates- Under this company manufactures Cefuroxime Acid, Cefaclor and many more.
API-Company has annual capacity of 2500MT of API under which it produces Ampicillin Trihydrat, Cloxacillin Sodium, Flucloxacillin Sodium, Cefprozil, Cefpodoxime Proxetil, Bacampicillin Hydrochloride, Oxacillin Sodium, Cefuroxime Axetil and many more.
Menthol- Under this company manufactures Menthol Powder, Menthol Crystals, Menthol Flakes, Essential Oil, Basil Oil, Dementholised Peppermint Oil, Natural Mint Terpenes, CIS-3-Hexenol, Menthones, Mentha Piperita Oil, Spearmint Oil and Menthyl Lactate. Company has annual production capacity of 4500 MT of Menthol Powder, 3600 MT of Menthol Crystals and 2800 MT of Dementholised Pepermint oil.
Herbal Products- Company manufactures products such as Quinine Sulphate, Quinine Hydrochloride, Colchicine, Thiocolchicoside, Raubasine, 5-HTP and 10-DAB III.
Company also conduct contract manufacturing for various companies.
Recent DevelopmentSurya Pharmaceutical plans to establish 500 healthcare and pharma retail stores in the next three years at an investment of Rs.250 crore. By March 2010, company would open 100 stores in the NCR (national capital region).